Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price hits fresh 52-week high

Caplin Point Laboratories Share Price is trading at Rs 2,678.40, down 1.34% from the previous close of Rs 2,714.70, after touching a fresh 52-week high of Rs 2,761.10. The company’s market capitalisation stands at Rs 20,606.39 crore. For investors tracking Caplin Point Laboratories Share Price Today, the move places the stock in focus in today’s Stock Market Today conversation because the price event is clear, even though the latest Univest data does not establish a company-specific catalyst.

Caplin Point Laboratories Stock News therefore centres on a verified one-year high rather than a broader event story. The stock opened at Rs 2,700.25 and moved between Rs 2,671.75 and Rs 2,761.10 so far in the current session. That range confirms the fresh 52-week high, while turnover of Rs 0.89 crore shows the value traded at the time of this update. In Univest terms, this is a precise Caplin Point Laboratories Share Price update built around factual price behaviour, valuation context and sector comparison.

Caplin Point Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,678.4
Previous Close	Rs 2,714.7
Today's Move	Rs -36.3 (-1.34%)
Open	Rs 2,700.25
High	Rs 2,761.1
Low	Rs 2,671.75
Turnover	Rs 0.89 crore
Market Capitalisation	Rs 20,606.39 crore

Caplin Point Laboratories Ltd. (CAPLIPOINT) traded at Rs 2,678.4 versus the previous close of Rs 2,714.7, a fall of 1.34%. The stock opened at Rs 2,700.25, reached a high of Rs 2,761.1 and touched a low of Rs 2,671.75.

Caplin Point Laboratories Share Price Today reflects a session that began above the previous close, reached a yearly high of Rs 2,761.10 and is now trading below that peak at Rs 2,678.40. The day change is Rs -36.30, or -1.34%, versus the previous close of Rs 2,714.70. The open at Rs 2,700.25 and the day low of Rs 2,671.75 show where the stock has moved inside the session’s range.

The fresh 52-week high is important because the current high matches the day high at Rs 2,761.10. Using the prior 52-week high as the reference point, the breakout percentage works out to 0.00% because the stock touched that exact level. For anyone scanning Caplin Point Laboratories Share Price, the price event is straightforward: the stock set a new yearly high and then traded lower from that level while remaining in the same broad price area. Caplin Point Laboratories Share News today is therefore a factual update on range expansion rather than a narrative with an unverified trigger.

Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 20,606.39 crore
P/E Ratio	31.01x
P/B Ratio	5.48x
ROE	21.72%
ROCE	26.22%
EPS	Rs 87.53
Book Value Per Share	Rs 495.39
Dividend Yield	0.15%

Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 31.01x, P/B 5.48x, ROE 21.72%, ROCE 26.22%. These figures provide context only and are not a buy or sell signal.

Caplin Point Laboratories Ltd. has a market capitalisation of Rs 20606.39 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.01x, P/B at 5.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.72% and ROCE of 26.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 87.53, book value per share of Rs 495.39, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.98x, median ROE of 11.78%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	31.01x
Benchmark Median P/E	31.98x
Benchmark Average P/E	48.7x
Benchmark P/E Range	3.49x to 648.54x
Company P/B Ratio	5.48x
Benchmark Median P/B	2.83x
Company ROE	21.72%
Benchmark Median ROE	11.78%
Company ROCE	26.22%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 20,606.39 crore
Benchmark Median Market Cap	Rs 692.19 crore

Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.01x, which is below the benchmark median of 31.98x, a difference of -3.03%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 21.72%, which is above the benchmark median of 11.78%, a difference of +84.38%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 26.22%, which is above the benchmark median of 13.61%, a difference of +92.65%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Granules India Ltd.	GRANULES	20,755.47	31.1	4.2	14.13	15.74
Pfizer Ltd.	PFIZER	21,329.88	28.79	4.8	17.16	23.39
Eris Lifesciences Ltd.	ERIS	17,989.5	27.83	4.43	13.81	13.59
Suven Pharmaceuticals Ltd.	COHANCE	17,589.91	165.3	4.56	4.02	6.12
Glenmark Life Sciences Ltd.	ALIVUS	17,413.9	28.88	5	18.41	24.61

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.01x compared with the displayed peer median of 28.88x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.72% compares with a peer median of 14.13% across the companies shown in the table. ROCE stood at 26.22% versus the displayed peer median of 15.74%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 20,606.39 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Caplin Point Laboratories

• Caplin Point Laboratories Share Price touched Rs 2,761.10, which is the fresh 52-week high in today’s trade.
• Caplin Point Laboratories Share Price Today is Rs 2,678.40, down 1.34% from the previous close of Rs 2,714.70.
• Market capitalisation stands at Rs 20,606.39 crore, above the same-industry median and average in the latest Univest sector snapshot.
• P/E is 31.01, P/B is 5.48, ROE is 21.72% and ROCE is 26.22%, giving a clear fundamental backdrop.
• Revenue was Rs 6,103.60 crore in June 2026, after Rs 6,001.60 crore in March 2026 and Rs 5,102.20 crore in June 2025.

About Caplin Point Laboratories

Caplin Point Laboratories Ltd. operates in Healthcare, within the Pharmaceuticals & Drugs industry. In Univest stock coverage, Caplin Point Laboratories Share Price is tracked alongside the company’s market capitalisation, valuation ratios and reported revenue trends. The latest company data places the business in a benchmarked industry set of 200 same-industry companies and 286 same-sector companies, which helps frame how the stock is viewed in broader market screens.

For readers comparing Caplin Point Laboratories Share Price Today with Caplin Point Laboratories Stock News and Caplin Point Laboratories Company News, the important point is that the current update is driven by a verified 52-week high and supported by the latest reported quarterly revenue figures, not by an unverified story line.

Frequently Asked Questions

Why did Caplin Point Laboratories Share Price hit a fresh 52-week high?

Ans. Caplin Point Laboratories Share Price touched Rs 2,761.10, which is its fresh 52-week high in the current session. The latest Univest update confirms the price event, but it does not establish a company-specific catalyst.

What is Caplin Point Laboratories Share Price today?

Ans. Caplin Point Laboratories Share Price today is Rs 2,678.40, compared with the previous close of Rs 2,714.70. The stock is trading at a fresh yearly high range while moving below that intraday peak.

What is the market capitalisation of Caplin Point Laboratories?

Ans. Caplin Point Laboratories has a market capitalisation of Rs 20,606.39 crore. In the latest same-industry benchmark, that is above the median of Rs 692.19 crore and also above the average of Rs 14,109.02 crore.

How do Caplin Point Laboratories P/E and P/B compare with the industry?

Ans. Caplin Point Laboratories has a P/E of 31.01 and a P/B of 5.48. The P/E is slightly below the same-industry median, while the P/B is above both the benchmark median and average.

What do ROE and ROCE show for Caplin Point Laboratories Share Price?

Ans. ROE is 21.72% and ROCE is 26.22% for Caplin Point Laboratories. Both are above the benchmark medians and averages in the latest industry snapshot, which adds useful context to the share price.

How does Caplin Point Laboratories compare with peers?

Ans. Caplin Point Laboratories Share Price is supported by a P/E of 31.01 and a market cap of Rs 20,606.39 crore. That places it close to Granules India on P/E and above several listed peers on return ratios.

What revenue figures are relevant for Caplin Point Laboratories?

Ans. Revenue was Rs 6,103.60 crore in June 2026, Rs 6,001.60 crore in March 2026 and Rs 5,102.20 crore in June 2025. These figures give Caplin Point Laboratories Share Price a recent operating context.

What should investors monitor next in Caplin Point Laboratories Share Price?

Ans. Investors can monitor how Caplin Point Laboratories Share Price behaves relative to the fresh 52-week high, the previous close, and the latest valuation metrics. Univest will continue to track price, ratios and sector context.

Track Caplin Point Laboratories Share Price on Univest

Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Caplin Point Laboratories Share Price on Univest to check live price updates, 52-week levels, valuation ratios, revenue trends, market capitalisation, and sector context in one place. Univest also helps you review Caplin Point Laboratories Share Price Live, Caplin Point Laboratories Latest News and Caplin Point Laboratories Stock Analysis with a single view of the latest market numbers.